Black people with type 1 diabetes, COVID-19 are four times more likely to be hospitalized for diabetic ketoacidosis

January 07, 2021

WASHINGTON--Black and Hispanic people with COVID-19 and diabetes are more likely than Caucasians to die or have serious complications, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

"This is the first major study to examine racial-ethnic inequities for people with type 1 diabetes and COVID-19 that are brought on by structural and systemic racism," said study author Osagie Ebekozien, M.D., M.P.H., of the T1D Exchange in Boston, Mass. "We used a diverse cohort of patients with type 1 diabetes and found there is a significantly increased risk of worse outcomes for Black and Hispanic patients with COVID-19 and diabetes."

The researchers analyzed data from 180 people with type 1 diabetes and COVID-19 from 52 clinical sites in the United States. The study found Black patients were four times more likely to be hospitalized for diabetic ketoacidosis than Caucasians. Black and Hispanic patients were also less likely to use diabetes technology like continuous glucose monitors (CGMs) and insulin pumps, and they had worse glycemic control than Caucasian patients.

"Our findings of troubling and significant inequities call for urgent and targeted interventions, such as culturally appropriate diabetic ketoacidosis awareness campaigns, increased continuous glucose monitoring coverage for minority patients and health care provider participation in a Quality Improvement Collaborative," Ebekozien said.
Other authors of the study include: Shivani Agarwal of the Albert Einstein College of Medicine in the Bronx, N.Y.; Nudrat Noor and Nicole Rioles of the T1D Exchange; Anastasia Albanese-O'Neil of the University of Florida in Gainesville, Fla.; Jenise C. Wong and Srinath Sanda of the Madison Clinic for Pediatric Diabetes at the University of California San Francisco in San Francisco, Calif.; Tossaporn Seeherunvong and Janine Sanchez of the University of Miami Miller School of Medicine in Miami, Fla.; Daniel DeSalvo, Sarah K. Lyons and Anna Cymbaluk of the Texas Children's Hospital at Baylor College of Medicine in Houston, Texas; Shideh Majidi and Guy Todd Alonso of the University of Colorado in Denver, Colo.; Jamie R. Wood of the Case Western Reserve University in Cleveland, Ohio; Runa Acharya of the SUNY Upstate Medical University in Syracuse, N.Y.; Grazia Aleppo of Northwestern University in Chicago, Ill.; Kathryn M. Sumpter of Le Bonheur Children's Hospital in Memphis, Tenn.; Nirali A. Shah of the Icahn School of Medicine at Mount Sinai in New York, N.Y.; Michelle Van Name and Lisa Cruz-Aviles of the Yale School of Medicine in New Haven, Conn.; Mary Pat Gallagher of NYU Langone Health in Brooklyn, N.Y.; Alexis Jamie Feuer of Weill Cornell Medicine in New York, N.Y.; Kristina Cossen of Children Healthcare of Atlanta in Atlanta, Ga.; Nana-Hawa Yayah Jones of the Cincinnati Children's Hospital Medical Center in Cincinnati, Ohio; Manmohan K. Kamboj of the Nationwide Children Hospital in Columbus, Ohio; and Irl B. Hirsch of the University of Washington School of Medicine in Seattle, Wash.

The manuscript received funding from the Juvenile Diabetes Research Foundation, the Insulet Corporation, Medtronic, Dexcom, Eli Lilly and Company, Tandem, the Leona M. and Harry B. Helmsley Charitable Trust, Abbott Diabetes Care, and the National Institute of Diabetes and Digestive and Kidney Diseases.

The manuscript, "Inequities in Diabetic Ketoacidosis among Patients with Type 1 Diabetes and COVID 19: Data from 52 US Clinical Centers," was published online, ahead of print.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at Follow us on Twitter at @TheEndoSociety and @EndoMedia.

The Endocrine Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to